Cargando…
The evidence base for emergency use authorizations for COVID‐19 treatments: A rapid review
BACKGROUND AND AIMS: During the COVID‐19 pandemic, US Food and Drug Administration (FDA) permitted emergency use authorizations (EUAs) for vaccines/treatments with promising data. Eight treatments were issued EUAs by May 31, 2021; one of these was approved (Remdesivir for certain populations) and tw...
Autores principales: | Knowlson, Catherine, Byrne, Ailish, Wilkinson, Jacqueline, Whitmore, Claire, Torgerson, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9831114/ https://www.ncbi.nlm.nih.gov/pubmed/36644312 http://dx.doi.org/10.1002/hsr2.1051 |
Ejemplares similares
-
Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial
por: Knowlson, Catherine, et al.
Publicado: (2020) -
Examination of early treatment effects and related biases during the conduct of two UK-wide pragmatic orthopaedic surgical trials: ProFHER and UK FROST
por: Knowlson, Catherine N., et al.
Publicado: (2023) -
Communication interventions for medically unexplained symptom conditions in general practice: A systematic review and meta-analysis of randomised controlled trials
por: Byrne, Ailish Katherine, et al.
Publicado: (2022) -
Rapid review of available evidence on the serial interval and generation time of COVID-19
por: Griffin, John, et al.
Publicado: (2020) -
Adapted treatment of ANCA-associated vasculitis during the COVID-19 pandemic
por: Nimmo, Ailish, et al.
Publicado: (2021)